163 related articles for article (PubMed ID: 37118443)
21. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis.
Wang A; Liu Y; Xiong W; Li W; Li J; Yang Z; Zou Z; Luo Y; Chen Z; Li H; Vong CT; Zou L
J Pharm Sci; 2024 Jun; ():. PubMed ID: 38901529
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis
Raj PM; Raj R; Kaul A; Mishra AK; Ram A
RSC Adv; 2018 Jun; 8(37):20809-20821. PubMed ID: 35542340
[TBL] [Abstract][Full Text] [Related]
23. QbD-Enabled Systematic Development of Ileo-Colonic Targeted Novel Mucoadhesive Microspheres of Flurbiprofen.
Pande S; Vashi J; Solanki A
Curr Drug Deliv; 2022; 19(3):407-419. PubMed ID: 34238189
[TBL] [Abstract][Full Text] [Related]
24. Colon-Targeting
Xu Y; Zhu BW; Sun R; Li X; Wu D; Hu JN
ACS Appl Mater Interfaces; 2023 Jun; 15(22):26298-26315. PubMed ID: 37233992
[TBL] [Abstract][Full Text] [Related]
25. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
[TBL] [Abstract][Full Text] [Related]
26. pH/ROS Dual-Sensitive Natural Polysaccharide Nanoparticles Enhance "One Stone Four Birds" Effect of Rhein on Ulcerative Colitis.
Qi S; Luo R; Han X; Nie W; Ye N; Fu C; Gao F
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50692-50709. PubMed ID: 36326017
[TBL] [Abstract][Full Text] [Related]
27. Eudragit-coated chitosan-tripterygium glycoside conjugate microspheres alleviate DSS-induced experimental colitis by inhibiting the TLR4/NF-κB signaling pathway.
Xue G; Xiong H; Wang S; Fu Y; Xie Y
Biomed Pharmacother; 2023 Feb; 158():114194. PubMed ID: 36916404
[TBL] [Abstract][Full Text] [Related]
28. pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Mahami S; Salehi M; Mehrabi M; Vahedi H; Hassani MS; Bitaraf FS; Omri A
Int J Biol Macromol; 2023 Jul; 244():125332. PubMed ID: 37302632
[TBL] [Abstract][Full Text] [Related]
29. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis.
Yan Y; Sun Y; Wang P; Zhang R; Huo C; Gao T; Song C; Xing J; Dong Y
Carbohydr Polym; 2020 Oct; 246():116660. PubMed ID: 32747292
[TBL] [Abstract][Full Text] [Related]
30. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines.
Suluvoy JK; Sakthivel KM; Guruvayoorappan C; Berlin Grace VM
Biomed Pharmacother; 2017 Jul; 91():1113-1121. PubMed ID: 28531922
[TBL] [Abstract][Full Text] [Related]
32. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
[TBL] [Abstract][Full Text] [Related]
33. Investigation of optimal extraction, antioxidant, and antimicrobial activities of Achillea biebersteinii and A. wilhelmsii.
Bashi DS; Fazly Bazzaz BS; Sahebkar A; Karimkhani MM; Ahmadi A
Pharm Biol; 2012 Sep; 50(9):1168-76. PubMed ID: 22881142
[TBL] [Abstract][Full Text] [Related]
34. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
35. 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Tang H; Xiang D; Wang F; Mao J; Tan X; Wang Y
Mol Med Rep; 2017 Mar; 15(3):1117-1122. PubMed ID: 28138699
[TBL] [Abstract][Full Text] [Related]
36. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
37. Colon targeted chitosan-melatonin nanotherapy for preclinical Inflammatory Bowel Disease.
Mohanbhai SJ; Sardoiwala MN; Gupta S; Shrimali N; Choudhury SR; Sharma SS; Guchhait P; Karmakar S
Biomater Adv; 2022 May; 136():212796. PubMed ID: 35929295
[TBL] [Abstract][Full Text] [Related]
38. Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation.
Varshosaz J; Minaiyan M; Khaleghi N
J Microencapsul; 2015; 32(3):211-23. PubMed ID: 25561026
[TBL] [Abstract][Full Text] [Related]
39. Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis.
Nasr M; Cavalu S; Saber S; Youssef ME; Abdelhamid AM; Elagamy HI; Kamal I; Gaafar AGA; El-Ahwany E; Amin NA; Girgis S; El-Sandarosy R; Mahmoud F; Rizk H; Mansour M; Hasaballah A; El-Rafi AA; El-Azez RA; Essam M; Mohamed D; Essam N; Mohammed OA
Biomed Pharmacother; 2022 Sep; 153():113409. PubMed ID: 36076534
[TBL] [Abstract][Full Text] [Related]
40. The investigation on sialic acid-modified pectin nanoparticles loaded with oxymatrine for orally targeting and inhibiting the of ulcerative colitis.
Zhao C; Yang X; Fan M; Tian L; Sun T; Sun C; Jiang T
Colloids Surf B Biointerfaces; 2024 Apr; 236():113809. PubMed ID: 38447446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
